CD303 Antibody (APC)

Este producto es parte de CLEC4C - C-type lectin domain family 4 member C
Product Graph
195€ (20 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
CD303 Antibody (APC)
category
Primary Antibodies
provider
Abbexa
reference
abx229329
tested applications
FCM

Description

CD303 Antibody (APC) is a Human Monoclonal Antibody against CD303.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
CD303
Host
Mouse
Reactivity
Human
Clonality
Monoclonal
Conjugation
APC
Isotype
IgG2a Kappa
Size 1
20 tests
Size 2
100 tests
Size 3
200 tests
Tested Applications
FCM
Buffer
PBS with 0.05% Proclin300, 1% BSA.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light. Do not freeze.
Dry Ice
No
UniProt ID
Q8WTT0
Gene ID
170482
Alias
C-type lectin domain family 4 member C,DLEC,HECL,BDCA2,CD303,BDCA-2,CLECSF7,CLECSF11,Blood dendritic cell antigen 2,Dendritic lectin
Background
Antibody anti-CLEC4C
Status
RUO

Descripción

CLEC4C, also known as CD303 or BDCA-2 (Blood Dendritic Cell Antigen 2), is a member of the C-type lectin domain family 4 of receptors and is highly specific to plasmacytoid dendritic cells (pDCs), a subset of immune cells that are crucial for antiviral responses. CLEC4C serves as a pattern recognition receptor (PRR), identifying and binding to carbohydrate structures on pathogens, which helps initiate immune responses. Unlike many other C-type lectins that are broadly expressed on various immune cells, CLEC4C is primarily expressed on pDCs, a unique cell type specializing in the secretion of large quantities of type I interferons (IFN-α/β) in response to viral infections. This exclusive expression gives CLEC4C a unique role in the immune system, particularly in antiviral defense and modulating immune responses in both innate and adaptive immunity. CLEC4C is involved in immune modulation by inhibiting type I interferon production when cross-linked, adding another layer to immune regulation. It is studied extensively in the context of autoimmune diseases and chronic infections because of its involvement in pDC-mediated responses. Furthermore, its specific expression on pDCs has made CLEC4C a target for therapeutic interventions aimed at modulating pDC activity in autoimmune diseases and certain cancers.

Related Products

FNab01753

anti- CLEC4C antibody

Involved in antigen-capturing. Target ligand into antigen processing and peptide-loading compartments for presentation to T-cells. May mediate potent inhibition of induction of IFN-alpha/beta expression in plasmacytoid dendritic cells. May act as a signaling receptor that activates protein-tyrosine kinases and mobilizes intracellular calcium. Does not seem to bind mannose.

Ver Producto
abx066170

Human C-Type Lectin Domain Family 4, Member C (CLEC4C) Protein

Recombinant C-Type Lectin Domain Family 4, Member C (CLEC4C) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).

Ver Producto
abx104153

C-Type Lectin Domain Family 4, Member C (CLEC4C) Antibody

Polyclonal Antibody to C-Type Lectin Domain Family 4, Member C (CLEC4C).

Ver Producto